Daiwa Securities Group Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 144 shares of EYPT stock, worth $1,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144
Previous 144
-0.0%
Holding current value
$1,510
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
152Shares Held
57.9MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$87.3 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$54.3 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$42.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$39.8 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$39.5 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $357M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...